News

NIH Funds to Be Tied to Financial Transparency


 

Institutions that receive funding from the National Institutes of Health soon will have to publicly post information about any significant financial interests related to their government-funded research under proposed federal regulations published May 21.

The proposed regulation, which has been in the works for about a year, follows several high-profile cases in which NIH-funded researchers failed to disclose large amounts of industry funding.

Federal regulations on this subject have not been updated since 1995

In a commentary published online by JAMA on May 24, Dr. Francis S. Collins, the director of NIH, and Sally J. Rockey, Ph.D., the acting director of the NIH Office of Extramural Research, wrote that the 1995 regulations needed to be “clarified and strengthened” in order to maintain the public's trust in federally funded research (doi: 10.1001/jama.2010.774).

“The public may not always understand the intricacies of rigorous science, but most individuals quickly grasp the concept of bias,” Dr. Collins and Dr. Rockey wrote in JAMA.

“Plain and simple, Americans do not want financial conflicts of interest to influence the federally funded research they hope will yield better ways to fight disease and improve health.”

Under the proposed regulation, researchers would be required to make broader disclosures, and institutions are given greater responsibility for determining whether a disclosed financial interest would impact research.

Currently, individual researchers are required to report only significant financial interests that could affect their NIH-funded research or any significant financial interest they have in a company whose own monetary interests could affect the research.

The proposed rule would require researchers to report all significant financial interests. It would then be the institution's responsibility to determine whether those interests could reasonably appear to affect their NIH-funded research.

Additionally, the proposal would lower the threshold for reporting financial interests from $10,000 down to $5,000 for all equity interests and payments for services.

Along with evaluating potential financial conflicts, institutions also would be required to create a management plan for every identified financial conflict of interest.

Such management plans would be aimed at either reducing or eliminating the conflict, and institutions would have to report those management plans to the NIH.

The proposed rule also aims to improve transparency regarding financial conflicts of interest. Under the rule, NIH would require every institution that receives NIH funding to post information on potential conflicts of interest on a publicly accessible Web site. Institutions would be required to post the researcher's name, role in the study, nature of the financial interest, and the approximate dollar value.

The public may comment on the proposed federal regulation until July 20; the rule is expected to be made final before the end of the year.

Recommended Reading

Kaiser Permanente PHR Streamlines Medical Practice
MDedge Rheumatology
Patients, Doctors Affect Health Care Disparity
MDedge Rheumatology
Policy & Practice : Want more health reform news? Subscribe to our podcast – search 'Policy & Practice' in the iTunes store
MDedge Rheumatology
Reform May Cover Most Uninsured Young Adults
MDedge Rheumatology
Medical Societies Sign New Disclosure Code : Transparency, consistency, and self-regulation are key to maintaining integrity and independence.
MDedge Rheumatology
Patients, Physicians Want Disclosure of Financial Ties
MDedge Rheumatology
ACP Seeks Changes to Health Reform Law
MDedge Rheumatology
ACP Initiative to Evaluate Value of Treatments, Diagnostics
MDedge Rheumatology
Changes in Physician Billing Could Save $7 Billion Yearly
MDedge Rheumatology
AMA Releases Health Insurer Code of Conduct
MDedge Rheumatology